In Silico Drug Design for Mycobacterium Tuberculosis and Development of Host Pathogen Interaction Network and Molecular Docking Procedures

Year : 2023 | Volume : 01 | Issue : 01 | Page : 1-16

    Keerthana S

  1. Student, Department of Biotechnology, M S Ramaiah University of Applied sciences, Bengaluru, Karnataka, India


Objective: A leading cause of illness is the contagious disease tuberculosis (TB), this infection with Mycobacterium tuberculosis complex (MTBC) particularly M. tuberculosis and M. africanum, is what causes tuberculosis. Diverse receptor proteins (mycobacterial proteins) with various 3D structures and functions were evaluated to access the multi-domain antimycobacterial action of ligands. The specific receptor proteins PDB ID: 3PTY, PDB ID: 4OW8, PDB ID: 5KWA and PDB ID: 3ZXR, were opted for this study to determine the antimicrobial activity and general suppression of the target bacteria. Method: In this research, Arabinosyltransferase C (3PTY), Protein kinase A (4OW8), Proteasomal ATPase (5KWA) and Glutamine synthetase (3ZXR) with 50 phytocompounds and their derivatives were nominated for determining the binding affinity with target proteins. This process was carried out computationally, proteins were generated from PDB and phytocompounds were generated from PubChem. Purification of target proteins by BIOVIA for Molecular docking which is tendered by Pyrx and visualization of the 3D structures of target proteins with ligands by BIOVIA. Physiological screening of ligands by ADMETlab 2.0 and generation of Ramachandran plots and Hydrophobicity by BIOVIA and PDBsum generate. Result: In this study, after the experimental analysis with different bioinformatics tools and software, 13 bioactive ligands with the greatest satisfactory interaction properties were chosen from 50 that are docked with the four different target mycobacterium proteins in this investigation. Conclusion: Using computational and bioinformatics methodologies, plant anti-MTB phytocompounds with specific combating activity against particular target proteins have been outlined, and the target protein with advantages associated has been discovered

Keywords: Contagious, diverse, suppression, purification, molecular docking, visualization, ADMET analysis

[This article belongs to International Journal of Molecular Biotechnological Research(ijmbr)]

How to cite this article: Keerthana S In Silico Drug Design for Mycobacterium Tuberculosis and Development of Host Pathogen Interaction Network and Molecular Docking Procedures ijmbr 2023; 01:1-16
How to cite this URL: Keerthana S In Silico Drug Design for Mycobacterium Tuberculosis and Development of Host Pathogen Interaction Network and Molecular Docking Procedures ijmbr 2023 {cited 2023 Mar 30};01:1-16. Available from:

Browse Figures


  1. Kwofie, S. K., Adobor, C., Quansah, E., Bentil, J., Ampadu, M., Miller III, W. A., & Wilson, M. D. (2020). Molecular docking and dynamics simulations studies of OmpATb identifies four potential novel natural product-derived anti-Mycobacterium tuberculosis compounds. Computers in Biology and Medicine, 122, 103811.
  2. Sudre, P., Ten Dam, G., & Kochi, A. (1992). Tuberculosis: a global overview of the situation today. Bulletin of the World Health Organization, 70(2), 149.
  3. Kanabalan, R. D., Lee, L. J., Lee, T. Y., Chong, P. P., Hassan, L., Ismail, R., & Chin, V. K. (2021). Human tuberculosis and Mycobacterium tuberculosis complex: A review on genetic diversity, pathogenesis and omics approaches in host biomarkers discovery. Microbiological research, 246, 126674.
  4. Migliori, G. B., Nardell, E., Yedilbayev, A., D’Ambrosio, L., Centis, R., Tadolini, M., … & Dara, M. (2019). Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe. European Respiratory Journal, 53(6).
  5. Das, N., Jena, P. K., & Pradhan, S. K. (2020). Arabinosyltransferase C enzyme of Mycobacterium tuberculosis, a potential drug target: An insight from molecular docking study. Heliyon, 6(2), e02693.
  6. Sundar, S., Thangamani, L., Manivel, G., Kumar, P., & Piramanayagam, S. (2019). Molecular docking, molecular dynamics and MM/PBSA studies of FDA approved drugs for protein kinase a of Mycobacterium tuberculosis; application insights of drug repurposing. Informatics in Medicine Unlocked, 16, 100210.
  7. Wu, Y., Hu, K., Li, D., Bai, L., Yang, S., Jastrab, J. B., … & Li, H. (2017). Mycobacterium tuberculosis proteasomal ATPase Mpa has a β‐grasp domain that hinders docking with the proteasome core protease. Molecular microbiology, 105(2), 227-241.
  8. Suresh, A. J., Ayyamperumal, E., Pachamuthu, M., Jesiya, F., & Surya, P. R. (2019). Design, synthesis, characterization and biological evaluation of some novel thiadiazole, imidazole and indole derivatives as antitubercular agents against target enzyme gluta mine synthetase i.
  9. Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., … & Bolton, E. E. (2019). PubChem 2019 update: improved access to chemical data. Nucleic acids research, 47(D1), D1102-D1109.
  10. Kumar, N. P., Moideen, K., Banurekha, V. V., Nair, D., & Babu, S. (2019, July). Plasma proinflammatory cytokines are markers of disease severity and bacterial burden in pulmonary tuberculosis. In Open forum infectious diseases (Vol. 6, No. 7, p. ofz257). US: Oxford University Press.
  11. Burley, S. K., Berman, H. M., Kleywegt, G. J., Markley, J. L., Nakamura, H., & Velankar, S. (2017). Protein Data Bank (PDB): the single global macromolecular structure archive. Protein Crystallography, 627-641.
  12. Pawar, S. S., & Rohane, S. H. (2021). Review on discovery studio: An important tool for molecular docking. Asian J. Res. Chem, 14(1), 86-88.
  13. Jamadagni, S. N., Godawat, R., & Garde, S. (2011). Hydrophobicity of proteins and interfaces: Insights from density fluctuations. Annual review of chemical and biomolecular engineering, 2, 147-171.
  14. Gopalakrishnan, K., Sowmiya, G., Sheik, S. S., & Sekar, K. (2007). Ramachandran plot on the web (2.0). Protein and peptide letters, 14(7), 669-671.
  15. Pagadala, N. S., Syed, K., & Tuszynski, J. (2017). Software for molecular docking: a review. Biophysical reviews, 9(2), 91-102.
  16. Beg, M., & Athar, F. (2020). Pharmacokinetic and molecular docking studies of Achyranthes aspera phytocompounds to exploring potential anti-tuberculosis activity. J Bacteriol Mycol Open Access, 8(1), 18-27.
  17. Siam, M. K. S., Shohan, M. U. S., & Zafroon, Z. (2020). Investigation of the anti-TB potential of selected alkaloid constituents using molecular docking approach. BioRxiv.
  18. Billones, J. B., Carrillo, M. C. O., Organo, V. G., Macalino, S. J. Y., Emnacen, I. A., & Sy, J. B. A. (2013). Virtual screening against Mycobacterium tuberculosis lipoate proligase B (MtbLipB) and in silico ADMET evaluation of top hits. Orient. J. Chem, 29(4), 1457-1468.
  19. Xu, W., Snell, L. M., Guo, M., Boukhaled, G., Macleod, B. L., Li, M., … & Brooks, D. G. (2021). Early innate and adaptive immune perturbations determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfection. Immunity, 54(3), 526-541.
  20. Sousa, J., Cá, B., Maceiras, A. R., Simões-Costa, L., Fonseca, K. L., Fernandes, A. I., … & Saraiva, M. (2020). Mycobacterium tuberculosis associated with severe tuberculosis evades cytosolic surveillance systems and modulates IL-1β production. Nature communications, 11(1), 1-14.
  21. Dutta, N. K., Klinkenberg, L. G., Vazquez, M. J., Segura-Carro, D., Colmenarejo, G., Ramon, F., & Karakousis, P. C. (2019). Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence. Science advances, 5(3), eaav2104.
  22. Gagneux, S. (2018). Ecology and evolution of Mycobacterium tuberculosis. Nature Reviews Microbiology, 16(4), 202-213.

Regular Issue Subscription Original Research
Volume 01
Issue 01
Received March 2, 2023
Accepted March 16, 2023
Published March 30, 2023